Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

JERSEY CITY, N.J., United States:   Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of

READ MORE

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

JERSEY CITY, N.J., United States:   VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in

READ MORE